In the past week, ADTX stock has gone up by 16.43%, with a monthly decline of -6.32% and a quarterly plunge of -76.58%. The volatility ratio for the week is 3.63%, and the volatility levels for the last 30 days are 5.00% for Aditxt Inc The simple moving average for the last 20 days is 11.09% for ADTX stock, with a simple moving average of -99.56% for the last 200 days.
Is It Worth Investing in Aditxt Inc (NASDAQ: ADTX) Right Now?
Moreover, the 36-month beta value for ADTX is 1.34. Analysts have varying opinions on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 1 as “hold,” and 0 as “sell.”
On June 25, 2025, ADTX’s average trading volume was 297.70K shares.
ADTX) stock’s latest price update
Aditxt Inc (NASDAQ: ADTX) has seen a rise in its stock price by 22.56 in relation to its previous close of 1.33. However, the company has experienced a 16.43% gain in its stock price over the last five trading sessions. prnewswire.com reported 2025-06-11 that — BV Market Projected to Reach $1.0 Billion in the U.S. by 2033 — — BV Affects 21 Million U.S. Women; As many as 50% Experience Recurrent BV Within Six Months of Treatment — SAN DIEGO, June 11, 2025 /PRNewswire/ — Women’s health innovator Evofem Biosciences, Inc. (OTCPK: EVFM) today announced that a study of SOLOSEC® (secnidazole) 2 g oral granules for recurrent bacterial vaginosis (BV) presented at the 2025 American College of Obstetricians and Gynecologists (ACOG) Annual Clinical and Scientific Meeting supports further development of SOLOSEC for the management of recurrent BV, a potential new indication. In a focused clinical study of 24 women with recurrent BV, once-weekly dosing with secnidazole oral granules (SOLOSEC) demonstrated efficacy matching or potentially surpassing outcomes of current CDC-recommended suppressive treatments.
ADTX Trading at -9.37% from the 50-Day Moving Average
After a stumble in the market that brought ADTX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -99.99% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ADTX starting from HRT FINANCIAL LP, who purchase 15,636 shares at the price of $1.50 back on Oct 15 ’24. After this action, HRT FINANCIAL LP now owns 25,434 shares of Aditxt Inc, valued at $23,454 using the latest closing price.
HRT FINANCIAL LP, the 10% Owner of Aditxt Inc, sale 25,534 shares at $1.17 during a trade that took place back on Oct 16 ’24, which means that HRT FINANCIAL LP is holding 0 shares at $29,875 based on the most recent closing price.
Stock Fundamentals for ADTX
Current profitability levels for the company are sitting at:
- -503547.72 for the present operating margin
- -6.57 for the gross margin
The net margin for Aditxt Inc stands at -459.61. The total capital return value is set at -1736.48. Equity return is now at value -191.76, with -85.91 for asset returns.
Based on Aditxt Inc (ADTX), the company’s capital structure generated 0.19 points at debt to capital in total, while cash flow to debt ratio is standing at -5.74. The debt to equity ratio resting at 0.24. The interest coverage ratio of the stock is -6336.51.
Currently, EBITDA for the company is -27.04 million with net debt to EBITDA at -0.0. When we switch over and look at the enterprise to sales, we see a ratio of 126.36. The receivables turnover for the company is 1.31for trailing twelve months and the total asset turnover is 0.0. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.08.
Conclusion
To wrap up, the performance of Aditxt Inc (ADTX) has been bad in recent times. The stock has received a mixed of “buy” and “hold” ratings from analysts. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
